The EUROMAX trial will test whether bivalirudin started in the ambulance and continued for 4 hours after primary PCI improves clinical outcomes compared with guideline-recommended standard-of-care heparin-based regimens , and will also provide information on the combination of bivalirudin with prasugrel or ticagrelor .